Literature DB >> 9607700

Long-term changes of ionotropic glutamate and GABA receptors after unilateral permanent focal cerebral ischemia in the mouse brain.

M Qü1, T Mittmann, H J Luhmann, A Schleicher, K Zilles.   

Abstract

Long-term hyperexcitability was found after unilateral, permanent middle cerebral artery occlusion in exofocal neocortical areas of the adult mouse [Mittmann et al. (1998) Neuroscience 85, 15-27]. The aim of the present study was to test the hypothesis in an identical paradigm of ischemia. whether alterations in the densities of both excitatory and inhibitory amino acid receptors may underlie these pathophysiological changes. Alterations in densities of [3H]dizocilpine, [3H]D,L-amino-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, [3H]kainate and [3H]muscimol binding sites were demonstrated with quantitative in vitro receptor autoradiography. All binding sites were severely reduced in the core of the ischemic lesion. A completely different reaction was found in the exofocal, histologically inconspicuous parts of the somatosensory cortex and the more remote neocortical areas of both hemispheres. The [3H]muscimol binding sites were significantly reduced four weeks after ischemia in the motor cortex, hindlimb representation area and exofocal parts of the primary and secondary somatosensory cortices of both hemispheres. The focus of the reduction in [3H]muscimol binding sites was found in lower layer V and upper layer VI. Contrastingly, the densities of [3H]dizocilpine binding sites were found to be increased in these areas, whereas those of [3H]D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and [3H]kainate binding sites did not show significant changes. The [3H]dizocilpine binding site density increased predominantly in layers III and IV. All binding sites were also reduced in the retrogradely reacting, gliotic part of the ipsilateral ventroposterior thalamic nucleus, whereas the [3H]D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites were increased in the surround of the ipsilateral nucleus and no changes in binding sites were seen in the whole contralateral nucleus. We conclude that permanent local ischemia leads to a long-term and widespread impairment of the normal balance between binding sites of excitatory and inhibitory neurotransmitter receptors in neocortical areas far away from the focus of the post-ischemic tissue damage. The imbalance comprises an up-regulation of the [3H]dizocilpine binding sites in the ion channels of N-methyl-D-aspartate receptors and a down-regulation of [3H]muscimol binding sites of the GABA(A) receptors in the ipsi- and contralateral neocortex. These changes at the receptor level explain the previously observed hyperexcitability with the appearance of epileptiform field potentials and the long duration of excitatory postsynaptic potentials four weeks after ischemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607700     DOI: 10.1016/s0306-4522(97)00656-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat.

Authors:  Jie Ding; Gang Fu; Yan Zhao; Zhenyong Cheng; Yang Chen; Bo Zhao; Wei He; Lian-Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.046

2.  Time-sensitive reorganization of the somatosensory cortex poststroke depends on interaction between Hebbian and homeoplasticity: a simulation study.

Authors:  Amarpreet Singh Bains; Nicolas Schweighofer
Journal:  J Neurophysiol       Date:  2014-10-01       Impact factor: 2.714

Review 3.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

Review 4.  Adult cortical plasticity following injury: Recapitulation of critical period mechanisms?

Authors:  M Nahmani; G G Turrigiano
Journal:  Neuroscience       Date:  2014-05-01       Impact factor: 3.590

5.  Transplanted neuroblasts differentiate appropriately into projection neurons with correct neurotransmitter and receptor phenotype in neocortex undergoing targeted projection neuron degeneration.

Authors:  J J Shin; R A Fricker-Gates; F A Perez; B R Leavitt; D Zurakowski; J D Macklis
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

6.  Long-lasting inhibition of presynaptic metabolism and neurotransmitter release by protein S-nitrosylation.

Authors:  Alena Rudkouskaya; Vasiliy Sim; Aabha A Shah; Paul J Feustel; David Jourd'heuil; Alexander A Mongin
Journal:  Free Radic Biol Med       Date:  2010-06-08       Impact factor: 7.376

7.  Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury.

Authors:  Chun-Shu Piao; Bogdan A Stoica; Junfang Wu; Boris Sabirzhanov; Zaorui Zhao; Rainier Cabatbat; David J Loane; Alan I Faden
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

8.  99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody.

Authors:  Francis G Blankenberg; Judy Kalinyak; Liping Liu; Maya Koike; Danye Cheng; Michael L Goris; Allan Green; Jean-Luc Vanderheyden; David C Tong; Midori Anne Yenari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-14       Impact factor: 9.236

Review 9.  Functional consequences of the disturbances in the GABA-mediated inhibition induced by injuries in the cerebral cortex.

Authors:  Barbara Imbrosci; Thomas Mittmann
Journal:  Neural Plast       Date:  2011-05-31       Impact factor: 3.599

Review 10.  Computational neurorehabilitation: modeling plasticity and learning to predict recovery.

Authors:  David J Reinkensmeyer; Etienne Burdet; Maura Casadio; John W Krakauer; Gert Kwakkel; Catherine E Lang; Stephan P Swinnen; Nick S Ward; Nicolas Schweighofer
Journal:  J Neuroeng Rehabil       Date:  2016-04-30       Impact factor: 5.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.